Christine Senn, PhD Appointed Senior Vice President, Head of Site-Sponsor Innovation at Advarra

Christine Senn, PhD

Advarra, the market leader in regulatory review solutions and clinical research technology for sites and sponsors, welcomes clinical industry veteran Christine Senn, PhD, as Senior Vice President, Head of Site-Sponsor Innovation. With extensive site leadership experience and a longstanding personal goal to drive site-sponsor collaboration, Senn will lead Advarra’s effort to remove barriers between stakeholders and connect a siloed clinical research ecosystem – ultimately, to accelerate clinical trials.

Responsibilities

At Advarra, Chistine Senn will serve as Chair of the Site-Sponsor Consortium – a collaborative body now in its second year – and as Chair of Advarra’s Customer Advisory Board. She will also drive and oversee the development of innovative ways to bring clinical trial sites and sponsors together in support of Advarra’s mission. Further, Senn is excited to expand and elevate Advarra’s tightknit site community that collaborates in an exclusive online portal to transform clinical research and culminates each year at the Onsemble Conference.

Senn Comments

“Fostering collaboration of all clinical research stakeholders has been important to me throughout my career,” said Christine Senn. “For decades, there has been a huge disparity between the good intention of sponsor leadership and the reality in practice at the site level. Advarra gets this – just look at its Longboat solution as evidence of the company’s commitment to connecting a currently disconnected ecosystem. I am inspired to lead Advarra’s mission and execute transformative ideas about how to accomplish it.”

Clinical Trial Career

Senn began her clinical trial career at the University of Vermont College of Medicine while pursuing her doctorate in clinical psychology. She then spent 16+ years in various leadership positions including Chief Operating Officer at IACT Health, which later became Centricity Research, a top site network with more than 40 clinical research sites in the U.S. and Canada. Senn was also the 2023 Chair of the Association of Clinical Research Professionals (ACRP), is an ACRP Fellow (FACRP), and is double certified as a Certified Clinical Research Coordinator (CCRC) and Certified Principal Investigator (CPI).

“Christine is an industry superstar with extensive clinical trial experience, particularly from the critical, patient-facing site perspective,” said Advarra CEO Gadi Saarony. “We are driving full throttle on our mission to connect the ecosystem of sites and sponsors, and Christine brings the expertise and tenacity to propel us forward in that effort with the ultimate goal of speeding trials.”

Christine Senn will be presenting at Advarra’s 35th annual Onsemble Conference March 18-21 in Phoenix, AZ. Onsemble is the industry’s largest gathering of clinical research site professionals, including cancer centers, children’s hospitals, research consortia, academic medical centers, healthcare systems, and more.

SourceAdvarra

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.